- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00245310
Indocyangreen Elimination in Cirrhosis and Acute Liver Failure
October 8, 2010 updated by: Heidelberg University
Evaluation of the Indocyangreen Elimination as a Prognostic Marker in Decompensated Cirrhosis and Acute Liver Failure
Indocyangreen (ICG)is totally biliary eliminated and corresponds to hepatocyte function and liver perfusion.
The ICG-clearance will be evaluated as a prognostic marker in liver disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
patients with acute liver failure or advanced liver disease will be studied.
ICG-clearance will be correlated with established clinical scores and outcome.
Study Type
Observational
Enrollment (Anticipated)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Heidelberg, Germany, 69120
- University of Heidelberg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 78 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Description
Inclusion Criteria:
- acute liver failure OR end-stage liver disease
- normal hepatic perfusion by doppler ultrasound
Exclusion Criteria:
- portal vein thrombosis
- allergy to ICG or iodine
- thyroid disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jens Encke, PD Dr. med., Heidelberg University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2005
Primary Completion (Actual)
October 1, 2010
Study Completion (Actual)
October 1, 2010
Study Registration Dates
First Submitted
October 25, 2005
First Submitted That Met QC Criteria
October 25, 2005
First Posted (Estimate)
October 27, 2005
Study Record Updates
Last Update Posted (Estimate)
October 11, 2010
Last Update Submitted That Met QC Criteria
October 8, 2010
Last Verified
November 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LiMON
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Cirrhosis
-
Postgraduate Institute of Medical Education and...Society for the Study of Liver Diseases, Chandigarh ( India )UnknownDecompensated Cirrhosis of LiverIndia
-
The Second Affiliated Hospital of Chongqing Medical...RecruitingFibrosis, Liver | Cirrhosis, LiverChina
-
SUUMC Central Military Hospital Dr Carol DavilaRecruiting
-
The Cleveland ClinicRecruiting
-
The Cleveland ClinicRecruitingCirrhosis, LiverUnited States
-
University of PittsburghNational Institute on Drug Abuse (NIDA)CompletedCirrhosis, LiverUnited States
-
Beth Israel Deaconess Medical CenterAmerican Association for the Study of Liver Diseases FoundationCompleted
-
Asian Institute of Gastroenterology, IndiaCompletedCirrhosis, LiverIndia
-
Sherief Abd-ElsalamUnknown
Clinical Trials on Indocyangreen (ICG) clearance
-
Huazhong University of Science and TechnologyUnknownCervical Cancer | Sentinel Lymph NodeChina
-
Azienda Socio Sanitaria Territoriale della Valle...RecruitingCopd | Bronchiectasis AdultItaly
-
University of PennsylvaniaCompleted
-
Third Affiliated Hospital, Sun Yat-Sen UniversityUnknown
-
The Second Hospital of Hebei Medical UniversityUnknown
-
Pulsion Medical Systems SEUnknownMalignant Neoplasm of BreastGermany
-
MetroHealth Medical CenterCompletedWounds and Injuries | ComaUnited States
-
Hill-RomCompleted
-
University of PittsburghCystic Fibrosis FoundationCompletedCystic FibrosisUnited States
-
Royal Brompton & Harefield NHS Foundation TrustCompleted